The abstract is read at the publisher; the summary is JClub's.
In two phase 3b HIV-1 trials, Roche cobas 6800 and Abbott RealTime assays showed marked discordance near low viral-load thresholds, with 92% vs 68% below 50 copies/mL.
- Why it matters: Low-level viremia categories are used to monitor ART response and interpret trial endpoints, but assay performance differences can create discordant classifications near decision thresholds.
- What they did: Stored paired plasma from adults with HIV-1 in two multicenter phase 3b trials (271 suppressed; 348 initiating ART) were re-tested with RealTime, with samples enriched for cobas 6800 results ≥50 copies/mL and concordance assessed at 50 and 200 copies/mL.
- The result: For cobas 6800 ≥50 copies/mL, RealTime was <50 copies/mL in 91/99 suppressed and 159/233 initiating ART; for cobas 6800 ≥200 copies/mL, RealTime was <200 copies/mL in 14/18 and 44/53, respectively.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.